Citadel Advisors »

Briacell Therapeutics Corp shares owned by Citadel Advisors

Quarter-by-quarter ownership of Briacell Therapeutics Corp (BCTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $86k 69k 1.24
2024-06-30 $19k 16k 1.14
2024-03-31 $102k 36k 2.86
2023-12-31 $205k 35k 5.85

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Briacell Therapeutics Corp

Redmond Asset Management
Vontobel Holding
Hrt Financial
Citadel Advisors
Onyx Bridge Wealth Group
Group One Trading
Summit Trail Advisors
LPL Financial
Cambridge Investment Research Advisors
HighTower Advisors
Concord Wealth Partners
Susquehanna International
National Bank Of Canada /fi/
Royal Bank of Canada
TD Waterhouse Canada

View all funds holding Briacell Therapeutics Corp